Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Corvus Pharmaceuticals In...

    NASDAQ: CRVS · Real-Time Price · USD
    5.42
    0.57 (11.75%)
    At close: Aug 15, 2025, 3:59 PM
    5.43
    0.28%
    After-hours: Aug 15, 2025, 07:49 PM EDT

    Corvus Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 85K 151K 367K 460K
    Gross Profit
    		 -85K -151K -367K -460K
    Operating Income
    		 -27.55M -23.41M -32.56M -38.63M
    Interest Income
    		 n/a n/a 654.00 n/a
    Pretax Income
    		 -62.29M -27.03M -41.31M -43.24M
    Net Income
    		 -62.29M -27.03M -41.31M -43.24M
    Selling & General & Admin
    		 8.16M 6.73M 7.51M 9.28M
    Research & Development
    		 19.39M 16.53M 24.47M 29.11M
    Other Expenses
    		 n/a n/a 587K 235K
    Operating Expenses
    		 27.55M 23.26M 32.56M 38.63M
    Interest Expense
    		 1.82M 1.58M 654K 15K
    Selling & Marketing Expenses
    		 n/a -151K -587K -235K
    Cost & Expenses
    		 27.55M 23.41M 32.56M 38.63M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 60.98M 48.02M 46.55M 41.85M
    Shares Outstanding (Diluted)
    		 60.98M 48.02M 46.55M 41.85M
    EPS (Basic)
    		 -1.02 -0.56 -0.89 -1.03
    EPS (Diluted)
    		 -1.02 -0.56 -0.89 -1.03
    EBITDA
    		 -27.55M -26.88M -40.94M -42.78M
    EBIT
    		 -60.47M -27.03M -41.31M -43.24M
    Depreciation & Amortization
    		 32.92M 151K 367K 460K

    Add to Watchlist